GABAPENTIN
- Product NDC
- 43547-389
- 11-digit product format
- 435470389
- Labeler code
- 43547
- Product ID
- 43547-389_287538e6-6170-46b6-b209-6ae74b376b8a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Solco Healthcare U.S., LLC
- Application
- ANDA205101
- Marketing category
- ANDA
- Marketing start
- 2016-11-20
- Marketing end
- 2022-09-23
- Substance
- GABAPENTIN
- Active strength
- 600 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43547-389-10 | 43547038910 | 100 TABLET in 1 BOTTLE (43547-389-10) | 100 tablet | 2016-11-20 | 2022-09-23 | No | No | Current |
| 43547-389-50 | 43547038950 | 500 TABLET in 1 BOTTLE (43547-389-50) | 500 tablet | 2016-11-20 | 2022-09-23 | No | No | Current |